
Dutch Bros Inc.
BROSDutch Bros Inc. is a drive-thru coffee chain founded in 1992 in Oregon. Known for its wide variety of coffee beverages and energetic customer service, it has grown to become a popular regional brand across the United States. The company emphasizes community engagement and a fun, philanthropic culture.
Company News
Dutch Bros is positioned for significant growth with plans to expand from 1,177 locations to 2,029 stores by 2029, targeting a total addressable market of 7,000 U.S. locations. The company's small drive-through format, strong same-store sales growth over nine consecutive quarters, and differentiated afternoon sales performance (75% after 10 a.m. ...
Dutch Bros has reached a 52-week high of $74.65, driven by strong quarterly results with 31% revenue growth and 8.3% same-shop sales increase. The company raised full-year guidance and demonstrated five consecutive quarters of transaction growth. With 1,177 locations across 25 states and plans to expand to 2,029 shops by 2029, Dutch Bros is posit...
The article recommends three growth stocks: Axon Enterprise, a law enforcement AI platform company with strong revenue growth and profitability; Dutch Bros, a rapidly expanding coffee chain with aggressive store expansion plans and accelerating sales; and MercadoLibre, Latin America's leading e-commerce and fintech platform showing exceptional gr...
For roughly $100, investors can choose between one share of Starbucks or one share each of Dutch Bros and Chipotle. While Starbucks is an established giant with recent positive momentum, Dutch Bros offers faster growth with 16% year-over-year location expansion, and Chipotle presents a turnaround opportunity despite recent underperformance. Buyin...
Three consumer growth stocks—Dutch Bros, Chipotle, and Cava—are trading below recent highs due to margin pressure and macroeconomic concerns rather than fundamental deterioration. The article suggests a $200 basket portfolio approach across all three could be an attractive long-term compounding opportunity for patient investors with a 5+ year...
